Skip to Main Content

1,701

Views

4

CrossRef citations to date

0

Altmetric

Original Article

Three-year safety and two-year effectiveness of etanercept in patients with rheumatoid arthritis in Japan: Results of long-term postmarketing surveillance

Hisashi YamanakaInstitute of Rheumatology, Tokyo Women’s Medical University, Tokyo, Japan; View further author information

,

Tomohiro HirosePfizer Japan Inc., Tokyo, Japan; Correspondence[email protected]
View further author information

,

Yutaka EndoPfizer Japan Inc., Tokyo, Japan; View further author information

,

Noriko SugiyamaPfizer Japan Inc., Tokyo, Japan; View further author information

,

Yuri FukumaPfizer Japan Inc., Tokyo, Japan; View further author information

,

Yosuke MorishimaPfizer Japan Inc., Tokyo, Japan; View further author information

,

Naonobu SugiyamaPfizer Japan Inc., Tokyo, Japan; View further author information

,

Noritoshi YoshiiPfizer Japan Inc., Tokyo, Japan; View further author information

,

Nobuyuki MiyasakaDepartment of Rheumatology, Tokyo Medical & Dental University, Tokyo, Japan; View further author information

&

Takao KoikeHokkaido Medical Center for Rheumatic Diseases, Sapporo, JapanView further author information

Citations (4)

Keep up to date with the latest research on this topic with citation updates for this article.

Articles from other publishers (4)